Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma

被引:67
|
作者
Berchtold, Sonja [1 ]
Gruenwald, Barbara [2 ]
Krueger, Achim [2 ]
Reithmeier, Anja [1 ]
Haehl, Teresa [1 ]
Cheng, Tao [3 ]
Feuchtinger, Annette [4 ]
Born, Diana [5 ]
Erkan, Mert [3 ,6 ]
Kleeff, Joerg [3 ]
Esposito, Irene [1 ]
机构
[1] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany
[2] Tech Univ Munich, Inst Expt Oncol & Therapy Res, D-80290 Munich, Germany
[3] Tech Univ Munich, Dept Surg, D-80290 Munich, Germany
[4] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt Pathol, Neuherberg, Germany
[5] Kantonspital Munsterlingen, Munsterlingen, Germany
[6] Koc Univ, Sch Med, Dept Surg, Istanbul, Turkey
基金
欧盟第七框架计划;
关键词
Collagen type V; beta; 1-integrin; Pancreatic ductal adenocarcinoma; Pancreatic stellate cells; Epithelial-stromal interaction; EHLERS-DANLOS-SYNDROME; STELLATE CELLS; EXTRACELLULAR-MATRIX; CANCER; EXPRESSION; STROMA; ADHESION; COL5A1; FIBRIL; IDENTIFICATION;
D O I
10.1016/j.canlet.2014.10.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Excessive matrix production by pancreatic stellate cells promotes local growth and metastasis of pancreatic ductal adenocarcinoma and provides a barrier for drug delivery. Collagen type V is a fibrillar, regulatory collagen up-regulated in the stroma of different malignant tumors. Here we show that collagen type V is expressed by pancreatic stellate cells in the stroma of pancreatic ductal adenocarcinoma and affects the malignant phenotype of various pancreatic cancer cell lines by promoting adhesion, migration and viability, also after treatment with chemotherapeutic drugs. Pharmacological and antibody-mediated inhibition of beta 1-integrin signaling abolishes collagen type V-induced effects on pancreatic cancer cells. Ablation of collagen type V secretion of pancreatic stellate cells by siRNA reduces invasion and proliferation of pancreatic cancer cells and tube formation of endothelial cells. Moreover, stable knockdown of collagen type V in pancreatic stellate cells reduces metastasis formation and angiogenesis in an orthotopic mouse model of ductal adenocarcinoma. In conclusion, paracrine loops involving cancer and stromal elements and mediated by collagen type V promote the malignant phenotype of pancreatic ductal adenocarcinoma and underline the relevance of epithelial-stromal interactions in the progression of this aggressive neoplasm. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 50 条
  • [11] TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
    Trauzold, A.
    Siegmund, D.
    Schniewind, B.
    Sipos, B.
    Egberts, J.
    Zorenkov, D.
    Emme, D.
    Roeder, C.
    Kalthoff, H.
    Wajant, H.
    ONCOGENE, 2006, 25 (56) : 7434 - 7439
  • [12] Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human pancreatic Ductal Adenocarcinoma
    O'Leary, Brianne R.
    Fath, Melissa A.
    Bellizzi, Andrew M.
    Hrabe, Jennifer E.
    Button, Anna M.
    Allen, Bryan G.
    Case, Adam J.
    Altekruses, Sean
    Wagner, Brett A.
    Buettner, Garry R.
    Lynch, Charles F.
    Hernandez, Brenda Y.
    Cozen, Wendy
    Beardsley, Robert A.
    Keene, Jeffery
    Henry, Michael D.
    Domann, Frederick E.
    Spitz, Douglas R.
    Mezhir, James J.
    CLINICAL CANCER RESEARCH, 2015, 21 (07) : 1741 - 1751
  • [13] ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth
    Rath, Nicola
    Morton, Jennifer P.
    Julian, Linda
    Helbig, Lena
    Kadir, Shereen
    McGhee, Ewan J.
    Anderson, Kurt I.
    Kalna, Gabriela
    Mullin, Margaret
    Pinho, Andreia V.
    Rooman, Ilse
    Samuel, Michael S.
    Olson, Michael F.
    EMBO MOLECULAR MEDICINE, 2017, 9 (02) : 198 - 218
  • [14] High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
    Li, He
    Li, Xiaocheng
    Lin, Huapeng
    Gong, Jianping
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 822 - 832
  • [15] Quasimesenchymal Phenotype Predicts Distant Metastasis in Pancreatic Ductal Adenocarcinoma
    Gupta, Rajib
    Mahadevan, Krishnan K.
    Ferrone, Cristina R.
    Ting, David T.
    Deshpande, Vikram
    MODERN PATHOLOGY, 2016, 29 : 441A - 441A
  • [16] Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma
    Mahadevan, Krishnan K.
    Arora, Kshitij S.
    Amzallag, Arnaud
    Williams, Erik
    Kulkarni, Anupriya S.
    Fernandez-del Castillo, Carlos
    Lillemoe, Keith D.
    Bardeesy, Nabeel
    Hong, Theodore S.
    Ferrone, Cristina R.
    Ting, David T.
    Deshpande, Vikram
    MODERN PATHOLOGY, 2019, 32 (06) : 844 - 854
  • [17] Quasimesenchymal Phenotype Predicts Distant Metastasis in Pancreatic Ductal Adenocarcinoma
    Gupta, Rajib
    Mahadevan, Krishnan K.
    Ferrone, Cristina R.
    Ting, David T.
    Deshpande, Vikram
    LABORATORY INVESTIGATION, 2016, 96 : 441A - 441A
  • [18] Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice
    Gopinathan, Aarthi
    DeNicola, Gina M.
    Frese, Kristopher K.
    Cook, Natalie
    Karreth, Florian A.
    Mayerle, Julia
    Lerch, Markus M.
    Reinheckel, Thomas
    Tuveson, David A.
    GUT, 2012, 61 (06) : 877 - 884
  • [19] Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma
    Penchev, Vesselin R.
    Chang, Yu-Tai
    Begum, Asma
    Ewachiw, Theodore
    Gocke, Christian
    Li, Joey
    McMillan, Ross H.
    Wang, Qiuju
    Anders, Robert
    Marchionni, Luigi
    Maitra, Anirban
    Uren, Aykut
    Rasheed, Zeshaan
    Matsui, William
    MOLECULAR CANCER RESEARCH, 2019, 17 (04) : 929 - 936
  • [20] A mucus production programme promotes classical pancreatic ductal adenocarcinoma
    Tonelli, Claudia
    Yordanov, Georgi N.
    Hao, Yuan
    Deschenes, Astrid
    Hinds, Juliene
    Belleau, Pascal
    Klingbeil, Olaf
    Brosnan, Erin
    Doshi, Abhishek
    Park, Youngkyu
    Hruban, Ralph H.
    Vakoc, Christopher R.
    Dobin, Alexander
    Preall, Jonathan
    Tuveson, David A.
    GUT, 2024, 73 (06) : 941 - 954